|Articles|March 15, 2003

Bimanual microphacoemulsification: the next phase?

Cataract removal by means of phacoemulsification has improved over the last 35 years in small, incremental steps. The sequential introductions of capsulorhexis, foldable IOLs, clear corneal incisions, and topical anesthesia have made small improvements in the safety andefficacy of cataract surgery and as a whole have taken us one giant leap forward.Bimanual phacoemulsification is just another one of these small steps that may ultimately enhance our ability to offer the best surgical procedure to our patients.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related to this article

June 20th, 2026

DSLT for glaucoma and ocular hypertension: Real-world outcomes in 218 eyes

A retrospective study finds that direct selective laser trabeculoplasty significantly lowers intraocular pressure, with the greatest benefit seen in treatment-naive eyes.

June 18th, 2026

IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLs

Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.

July 30th, 2026

Frantz EyeCare LAL outcomes exceed national benchmarks in single-center cataract data

Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.

July 23rd, 2026

Emerging dry eye therapies and co-managing MGD: Ping Moore, OD

In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.